Cyclica (acquired by Recursion, Nasdaq: RXRX)
Biotechnology ResearchOntario, Canada2-10 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Recent Company Growth Cyclica has been acquired by Recursion, indicating a strategic move to expand its biotech capabilities, which could mean increased investment in data analytics and research tools tailored for biotech firms.
Market Expansion The launch of Beacons for Brands and the introduction of an integrated affiliate marketplace demonstrate a focus on content monetization and brand collaboration, presenting opportunities to offer AI-driven marketing and engagement solutions.
Funding & Revenue With $6 million in seed funding and revenue estimated between 1 to 10 million dollars, there is a growing interest and budget for innovative SaaS and biotech solutions, making this an opportune time for targeted sales efforts.
Technology Stack Utilization of modern platforms like Profitwell, Chargebee, and PWA indicates openness to adopting scalable, cloud-based SaaS tools, suggesting potential for upselling advanced analytics, billing, and engagement solutions.
Competitive Landscape While Cyclica operates in a competitive biotech research environment, its strategic acquisition and focus on AI-driven content creation for creators and brands signal a unique market positioning that can be leveraged for tailored partnership opportunities.
Cyclica (acquired by Recursion, Nasdaq: RXRX) uses 8 technology products and services including Profitwell, cdnjs, Canny, and more. Explore Cyclica (acquired by Recursion, Nasdaq: RXRX)'s tech stack below.
| Cyclica (acquired by Recursion, Nasdaq: RXRX) Email Formats | Percentage |
| First.Last@cyclicarx.com | 100% |
| First@beacons.ai | 87% |
| Last@beacons.ai | 12% |
| FirstL@beacons.ai | 1% |
Biotechnology ResearchOntario, Canada2-10 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M